186 results on '"Espígol-Frigolé, Georgina"'
Search Results
2. Decoding CD4+ T cell transcriptome in giant cell arteritis: Novel pathways and altered cross-talk with monocytes
3. Maternal and fetal outcomes of pregnancy in women with primary systemic vasculitis: A single-center cohort study of 20 patients and 30 pregnancies
4. Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study
5. Polymyalgia rheumatica
6. Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis
7. Significance of clinical‐immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis.
8. Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences aboutUBA1mosaicism
9. Biological treatments in giant cell arteritis & Takayasu arteritis
10. Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis
11. Maternal and Fetal Outcomes of Pregnancy in Women with Primary Systemic Vasculitis: A Single-Center Cohort Study of 20 Patients and 30 Pregnancies
12. Methylome and transcriptome profiling of giant cell arteritis monocytes reveals novel pathways involved in disease pathogenesis and molecular response to glucocorticoids
13. MO241: Nets and Terminal Complement Pathway as Potential Biomarkers for Complement Overactivation Assessment in Anca-Associated Vasculitis
14. Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis
15. Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis
16. Aetiology and pathogenesis
17. Risks and benefits of tocilizumab monotherapy in giant cell arteritis
18. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis
19. An 80-year-old man with headache, orbital pain and elevated ESR: challenges in the diagnosis of a patient with suspected giant cell arteritis
20. Evaluation of Aortic Inflammation Using Computed Tomographic Angiography: Vasculitis, Atherosclerosis, or Both
21. Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection.
22. Authors’ response to the eLetter by Moiseev et al
23. Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation)
24. A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center
25. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case–control study
26. Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis
27. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis
28. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status
29. Cytokines and Vascular Inflammation
30. Functionally Relevant Treg Cells Are Present in Giant Cell Arteritis Lesions: Comment on the Article by Samson et al
31. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography
32. 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative
33. Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis—a prospective longitudinal study
34. Central Nervous System Vasculitis: Still More Questions than Answers
35. Treatment of Large Vessel Vasculitis
36. Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies
37. Small-vessel vasculitis surrounding an uninflamed temporal artery as a diagnostic criterion for polymyalgia rheumatica: Comment on the article by Chatelain et al
38. Aortic involvement in patients with newly diagnosed giant cell arteritis (GCA). A prospective study using computed tomography (CT) angiography: E3
39. The spectrum of vascular involvement in giant-cell arteritis: clinical consequences of detrimental vascular remodelling at different sites
40. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status
41. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status
42. Sustained Spontaneous Clinical Remission in Giant Cell Arteritis: Report of Two Cases With Long-Term Followup
43. Expression and function of IL12/23 related cytokine subunits (p35, p40, and p19) in giant-cell arteritis lesions: contribution of p40 to Th1- and Th17-mediated inflammatory pathways
44. A very late presentation of polymyalgia rheumatica in a patient with giant cell arteritis: recurrence or casual association?
45. Utilisation des biothérapies dans le traitement des vascularites urticariennes
46. Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways
47. Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients
48. The Expanding Role of Imaging in Systemic Vasculitis
49. Relapses in Patients With Giant Cell Arteritis
50. Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.